BOSTON SCIENTIFIC CORPORATION Equity Method Investment, Other than Temporary Impairment
BOSTON SCIENTIFIC CORPORATION (BSX) reported Equity Method Investment, Other than Temporary Impairment of $16.00 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-17.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2011-02-17
- BOSTON SCIENTIFIC CORPORATION equity method investment, other than temporary impairment for fiscal 2010 was $16.00M, a 14.29% increase from fiscal 2009.
- BOSTON SCIENTIFIC CORPORATION equity method investment, other than temporary impairment for fiscal 2009 was $14.00M, a 89.23% decline from fiscal 2008.
- BOSTON SCIENTIFIC CORPORATION equity method investment, other than temporary impairment for fiscal 2008 was $130.00M.
| Period end | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|
| 2010-12-31 | $16.00M 10-K · filed 2011-02-17 |
| 2009-12-31 | $14.00M 10-K · filed 2011-02-17 |
| 2008-12-31 | $130.00M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |